NCT02509767 - Depo Provera Self-Administration Study: Putting a Patient-Centered Practice to the Test at Planned Parenthood | Biotech Hunter

Enrollment

401

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

April 30, 2017

Study Completion Date

December 31, 2017

Conditions

Contraception

Interventions

DRUG

Subcutaneous depot medroxyprogesterone acetate

Based on study arm, subjects will either be taught to self-inject or will be administered DMPA sc by qualified clinic personnel.

Trial Locations (2)

Planned Parenthood Gulf Coast, Houston

Planned Parenthood of Central and Greater Northern New Jersey, Morristown